Draft guidance consultation
Closed for comments This consultation ended on at Request commenting lead permission
ID6130 leniolisib APDS DG to PM for consultation - Web version 281024VM [noCON].docx
Leniolisib for activated phosphoinositide 3‑kinase delta syndrome in people 12 years and over
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation